chr22-41515521-C-T

Variant summary

Our verdict is Benign. Variant got -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1

The NM_001098.3(ACO2):​c.670C>T​(p.Leu224Leu) variant causes a synonymous change. The variant allele was found at a frequency of 0.462 in 1,610,822 control chromosomes in the GnomAD database, including 181,559 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.37 ( 12096 hom., cov: 31)
Exomes 𝑓: 0.47 ( 169463 hom. )

Consequence

ACO2
NM_001098.3 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 3.87
Variant links:
Genes affected
ACO2 (HGNC:118): (aconitase 2) The protein encoded by this gene belongs to the aconitase/IPM isomerase family. It is an enzyme that catalyzes the interconversion of citrate to isocitrate via cis-aconitate in the second step of the TCA cycle. This protein is encoded in the nucleus and functions in the mitochondrion. It was found to be one of the mitochondrial matrix proteins that are preferentially degraded by the serine protease 15(PRSS15), also known as Lon protease, after oxidative modification. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -18 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.41).
BP6
Variant 22-41515521-C-T is Benign according to our data. Variant chr22-41515521-C-T is described in ClinVar as [Benign]. Clinvar id is 128257.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr22-41515521-C-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.5 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ACO2NM_001098.3 linkuse as main transcriptc.670C>T p.Leu224Leu synonymous_variant 5/18 ENST00000216254.9 NP_001089.1 Q99798

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ACO2ENST00000216254.9 linkuse as main transcriptc.670C>T p.Leu224Leu synonymous_variant 5/181 NM_001098.3 ENSP00000216254.4 Q99798

Frequencies

GnomAD3 genomes
AF:
0.368
AC:
55803
AN:
151694
Hom.:
12097
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.158
Gnomad AMI
AF:
0.413
Gnomad AMR
AF:
0.307
Gnomad ASJ
AF:
0.461
Gnomad EAS
AF:
0.216
Gnomad SAS
AF:
0.375
Gnomad FIN
AF:
0.437
Gnomad MID
AF:
0.389
Gnomad NFE
AF:
0.505
Gnomad OTH
AF:
0.355
GnomAD3 exomes
AF:
0.390
AC:
96698
AN:
247828
Hom.:
21305
AF XY:
0.404
AC XY:
54107
AN XY:
133954
show subpopulations
Gnomad AFR exome
AF:
0.157
Gnomad AMR exome
AF:
0.209
Gnomad ASJ exome
AF:
0.445
Gnomad EAS exome
AF:
0.177
Gnomad SAS exome
AF:
0.384
Gnomad FIN exome
AF:
0.441
Gnomad NFE exome
AF:
0.500
Gnomad OTH exome
AF:
0.415
GnomAD4 exome
AF:
0.472
AC:
689110
AN:
1459010
Hom.:
169463
Cov.:
65
AF XY:
0.472
AC XY:
342680
AN XY:
725664
show subpopulations
Gnomad4 AFR exome
AF:
0.143
Gnomad4 AMR exome
AF:
0.219
Gnomad4 ASJ exome
AF:
0.449
Gnomad4 EAS exome
AF:
0.290
Gnomad4 SAS exome
AF:
0.388
Gnomad4 FIN exome
AF:
0.444
Gnomad4 NFE exome
AF:
0.510
Gnomad4 OTH exome
AF:
0.429
GnomAD4 genome
AF:
0.367
AC:
55784
AN:
151812
Hom.:
12096
Cov.:
31
AF XY:
0.363
AC XY:
26924
AN XY:
74172
show subpopulations
Gnomad4 AFR
AF:
0.157
Gnomad4 AMR
AF:
0.307
Gnomad4 ASJ
AF:
0.461
Gnomad4 EAS
AF:
0.216
Gnomad4 SAS
AF:
0.375
Gnomad4 FIN
AF:
0.437
Gnomad4 NFE
AF:
0.505
Gnomad4 OTH
AF:
0.350
Alfa
AF:
0.471
Hom.:
26043
Bravo
AF:
0.342
Asia WGS
AF:
0.278
AC:
969
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:3
Benign, criteria provided, single submitterclinical testingPreventionGenetics, part of Exact Sciences-- -
Benign, criteria provided, single submitterclinical testingGeneDxSep 09, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Likely benign, no assertion criteria providedclinical testingGenetic Services Laboratory, University of Chicago-Likely benign based on allele frequency in 1000 Genomes Project or ESP global frequency and its presence in a patient with a rare or unrelated disease phenotype. NOT Sanger confirmed. -
not provided Benign:3
Benign, no assertion criteria providedclinical testingMayo Clinic Laboratories, Mayo ClinicFeb 11, 2016- -
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -
Optic atrophy 9 Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -
Infantile cerebellar-retinal degeneration Benign:1
Benign, criteria provided, single submitterclinical testingGenome-Nilou LabJul 14, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.41
CADD
Benign
9.8
DANN
Benign
0.75

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1799932; hg19: chr22-41911525; COSMIC: COSV53441563; COSMIC: COSV53441563; API